Lends to development-stage technology and life-science businesses, plus healthcare and sustainability companies, mainly through secured loans and warrants.
10-K for FY2025, filed Mar 3, 2026
Portfolio companies pay interest and fees on secured loans, with principal repaid through scheduled payments; warrants can also produce gains if a borrower’s equity rises.
10-K for FY2025, filed Mar 3, 2026Structured investments in the venture capital and private and public equity markets. We make loans to development-stage companies within…View ↗
Creative products with attractive risk-adjusted pricing. Each of our existing and prospective portfolio companies has its own unique…View ↗
Opportunity for enhanced returns. To enhance our debt investment portfolio returns, in addition to interest and fees, we frequently obtain…View ↗
$45.5M
10-K for FY2025, filed Mar 3, 2026
$45.5M ↗
Lends directly to development-stage technology and life-science companies, as well as healthcare and sustainability businesses; borrowers include venture-capital and private-equity-backed firms and publicly traded companies.
10-K for FY2025, filed Mar 3, 2026
No. It lost $2.7M in FY2025.
10-K for FY2025, filed Mar 3, 2026
10-K for FY2025, filed Mar 3, 2026
−$2.7MView ↗
10-Q for Q2 FY2026, filed Aug 4, 2026
−$37.3MView ↗
8-K, filed May 14, 2026
On May 13, 2026, the Board of Directors (the “Board”) of Horizon Technology Finance Corporation (the “Company”) dismissed RSM US LLP…View ↗
8-K, filed Apr 14, 2026
Farmington, Connecticut – April 14, 2026 – Horizon Technology Finance Corporation (NASDAQ: HRZN) (“Horizon” or the “Company”) announced…View ↗
Growing. Revenue grew 59% in 4 years, from $28.6M in FY2021 to $45.5M in FY2025, about 12% a year.
Loading...